Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016.

Karlowsky JA, Lagacé-Wiens PRS, Adam HJ, Baxter MR, Laing NM, Walkty AJ, Zhanel GG.

Int J Antimicrob Agents. 2019 Jul;54(1):62-68. doi: 10.1016/j.ijantimicag.2019.04.012. Epub 2019 Apr 26.

PMID:
31034938
2.

Frequency of 16S ribosomal RNA methyltransferase detection among Escherichia coli and Klebsiella pneumoniae clinical isolates obtained from patients in Canadian hospitals (CANWARD, 2013-2017).

Walkty A, Karlowsky JA, Baxter MR, Adam HJ, Boyd D, Bharat A, Mulvey MR, Charles M, Bergevin M, Zhanel GG.

Diagn Microbiol Infect Dis. 2019 Jun;94(2):199-201. doi: 10.1016/j.diagmicrobio.2018.12.005. Epub 2018 Dec 14.

PMID:
30638654
3.

In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.

Karlowsky JA, Adam HJ, Baxter MR, Denisuik AJ, Lagacé-Wiens PRS, Walkty AJ, Puttagunta S, Dunne MW, Zhanel GG.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01832-18. doi: 10.1128/AAC.01832-18. Print 2019 Jan.

PMID:
30397056
4.

In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study.

Walkty A, Karlowsky JA, Baxter MR, Adam HJ, Zhanel GG.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e02068-18. doi: 10.1128/AAC.02068-18. Print 2019 Jan.

PMID:
30373806
5.

Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease.

Ihara R, Vincent BD, Baxter MR, Franklin EE, Hassenstab JJ, Xiong C, Morris JC, Cairns NJ.

Ann Neurol. 2018 Nov;84(5):741-753. doi: 10.1002/ana.25344. Epub 2018 Oct 25.

PMID:
30246887
6.

Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.

Adam HJ, Golden AR, Karlowsky JA, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii12-vii19. doi: 10.1093/jac/dky158.

PMID:
29982572
7.

Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.

Karlowsky JA, Adam HJ, Golden AR, Baxter MR, Nichol KA, Martin I, Demczuk W, Mulvey MR, Gilmour MW, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii5-vii11. doi: 10.1093/jac/dky156.

PMID:
29982570
8.

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015.

Karlowsky JA, Adam HJ, Kosowan T, Baxter MR, Nichol KA, Laing NM, Golding G, Zhanel GG.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):105-111. doi: 10.1016/j.diagmicrobio.2018.01.017. Epub 2018 Jan 31.

PMID:
29456070
9.

In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015.

Zhanel GG, Baxter MR, Adam HJ, Sutcliffe J, Karlowsky JA.

Diagn Microbiol Infect Dis. 2018 May;91(1):55-62. doi: 10.1016/j.diagmicrobio.2017.12.013. Epub 2017 Dec 22.

PMID:
29338931
10.

Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.

Lagacé-Wiens PRS, Adam HJ, Laing NM, Baxter MR, Martin I, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG.

J Antimicrob Chemother. 2017 Aug 1;72(8):2273-2277. doi: 10.1093/jac/dkx147.

PMID:
28505331
11.

In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015.

Karlowsky JA, Walkty AJ, Baxter MR, Arhin FF, Moeck G, Adam HJ, Zhanel GG.

Diagn Microbiol Infect Dis. 2017 Apr;87(4):349-356. doi: 10.1016/j.diagmicrobio.2017.01.006. Epub 2017 Jan 20.

PMID:
28159446
12.

Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.

Golden AR, Rosenthal M, Fultz B, Nichol KA, Adam HJ, Gilmour MW, Baxter MR, Hoban DJ, Karlowsky JA, Zhanel GG.

J Antimicrob Chemother. 2015 Aug;70(8):2199-202. doi: 10.1093/jac/dkv107. Epub 2015 Apr 28.

PMID:
25921512
13.

Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.

Golden AR, Adam HJ, Gilmour MW, Baxter MR, Martin I, Nichol KA, Demczuk WH, Hoban DJ, Zhanel GG.

J Antimicrob Chemother. 2015 Jul;70(7):1960-4. doi: 10.1093/jac/dkv061. Epub 2015 Mar 11.

PMID:
25761605
14.

In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013.

Karlowsky JA, Walkty AJ, Baxter MR, Adam HJ, Zhanel GG.

Diagn Microbiol Infect Dis. 2014 Dec;80(4):311-5. doi: 10.1016/j.diagmicrobio.2014.09.003. Epub 2014 Sep 16.

PMID:
25294303
15.

In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.

Karlowsky JA, Denisuik AJ, Lagacé-Wiens PR, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2014;58(2):1252-6. doi: 10.1128/AAC.02399-13. Epub 2013 Dec 9.

16.

In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.

Karlowsky JA, Adam HJ, Baxter MR, Lagacé-Wiens PR, Walkty AJ, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2013 Nov;57(11):5600-11. doi: 10.1128/AAC.01485-13. Epub 2013 Aug 26.

17.

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.

Zhanel GG, Adam HJ, Baxter MR, Fuller J, Nichol KA, Denisuik AJ, Lagacé-Wiens PR, Walkty A, Karlowsky JA, Schweizer F, Hoban DJ; Canadian Antimicrobial Resistance Alliance.

J Antimicrob Chemother. 2013 May;68 Suppl 1:i7-22. doi: 10.1093/jac/dkt022.

PMID:
23587781
18.

Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.

Adam HJ, Baxter MR, Davidson RJ, Rubinstein E, Fanella S, Karlowsky JA, Lagacé-Wiens PR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

J Antimicrob Chemother. 2013 May;68 Suppl 1:i31-7. doi: 10.1093/jac/dkt024.

PMID:
23587776
19.

Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.

Lagacé-Wiens PR, Adam HJ, Low DE, Blondeau JM, Baxter MR, Denisuik AJ, Nichol KA, Walkty A, Karlowsky JA, Mulvey MR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance.

J Antimicrob Chemother. 2013 May;68 Suppl 1:i23-9. doi: 10.1093/jac/dkt023.

PMID:
23587775
20.

Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.

Karlowsky JA, Walkty AJ, Adam HJ, Baxter MR, Hoban DJ, Zhanel GG.

Antimicrob Agents Chemother. 2012 Mar;56(3):1247-52. doi: 10.1128/AAC.05823-11. Epub 2011 Dec 27.

21.

Ondansetron is a better prophylactic antiemetic than droperidol for tonsillectomy in children.

Splinter WM, Rhine EJ, Roberts DW, Baxter MR, Gould HM, Hall LE, MacNeill HB.

Can J Anaesth. 1995 Oct;42(10):848-51.

PMID:
8706191
22.

Oral ondansetron decreases vomiting after tonsillectomy in children.

Splinter WM, Baxter MR, Gould HM, Hall LE, MacNeill HB, Roberts DJ, Komocar L.

Can J Anaesth. 1995 Apr;42(4):277-80.

PMID:
7788823
23.

The welfare problems of laying hens in battery cages.

Baxter MR.

Vet Rec. 1994 Jun 11;134(24):614-9. Review.

PMID:
7941260
24.

Congenital laryngomalacia.

Baxter MR.

Can J Anaesth. 1994 Apr;41(4):332-9. Review.

PMID:
8004741
25.

Onset of maximum neuromuscular block following succinylcholine or vecuronium in four age groups.

Koscielniak-Nielsen ZJ, Bevan JC, Popovic V, Baxter MR, Donati F, Bevan DR.

Anesthesiology. 1993 Aug;79(2):229-34.

PMID:
8102040
26.

Postoperative neuromuscular function in pediatric day-care patients.

Baxter MR, Bevan JC, Samuel J, Donati F, Bevan DR.

Anesth Analg. 1991 Apr;72(4):504-8.

PMID:
1672489
27.

Intensive housing: the last straw for pigs?

Baxter MR.

J Anim Sci. 1989 Sep;67(9):2433-40. Review.

PMID:
2689421
28.

The management of two pediatric patients with sickle cell trait and sickle cell disease during cardiopulmonary bypass.

Baxter MR, Bevan JC, Esseltine DW, Bernstein M.

J Cardiothorac Anesth. 1989 Aug;3(4):477-80. No abstract available.

PMID:
2520923
29.

Repair of RA-1000 probes.

Baxter MR, Hinds JA, Gollogly JR, Duffy P.

Clin Chem. 1988 Nov;34(11):2379. No abstract available.

PMID:
3180448
30.

Cleaning of RA-1000 probes.

Baxter MR, Hinds JA, Gollogly JR, Duffy P.

Clin Chem. 1988 Oct;34(10):2156-7. No abstract available.

PMID:
3168242
31.

Sickle cell states and the anaesthetist.

Esseltine DW, Baxter MR, Bevan JC.

Can J Anaesth. 1988 Jul;35(4):385-403. Review. No abstract available.

PMID:
3042181
32.

How to delineate the sow's welfare needs.

Baxter MR, Baxter SH.

Ann Rech Vet. 1984;15(2):281-6.

PMID:
6486699
33.

Intramural hematoma of the duodenum; report of a case with an unusual complication.

ROWE EB, BAXTER MR, ROWE CW.

AMA Arch Surg. 1959 Apr;78(4):560-4. No abstract available.

PMID:
13636654
34.

Acute erythroblastopenia; pathogenesis, manifestations and management.

MIESCH DC, BAXTER MR, LEVIN WC.

AMA Arch Intern Med. 1957 Mar;99(3):461-73. No abstract available.

PMID:
13402251
35.

[Clinical studies of dicurin procaine (Lilly) and of SU-1775 (Ciba)].

BAXTER MR, HEJTMANCIK MR, HERRMANN GR.

Tex State J Med. 1954 Apr;50(4):214-7. Undetermined Language. No abstract available.

PMID:
13156995
36.

[Diamox: new oral nonmercurial, nontoxic diuretic for the treatment of congestive heart failure].

HERRMANN GR, BAXTER MR, HEJTMANCIK MR, MORAN AR.

Tex State J Med. 1954 Apr;50(4):209-13. Undetermined Language. No abstract available.

PMID:
13156994

Supplemental Content

Loading ...
Support Center